Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Amortization of Deferred Charges (2016 - 2019)

Aethlon Medical filings provide 9 years of Amortization of Deferred Charges readings, the most recent being $30287.0 for Q1 2019.

  • On a quarterly basis, Amortization of Deferred Charges changed 0.0% to $30287.0 in Q1 2019 year-over-year; TTM through Mar 2019 was $121148.0, a 50.69% decrease, with the full-year FY2020 number at $30287.0, down 75.0% from a year prior.
  • Amortization of Deferred Charges hit $30287.0 in Q1 2019 for Aethlon Medical, roughly flat from $30287.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $156597.0 in Q1 2016 to a low of $18998.0 in Q3 2016.
  • Median Amortization of Deferred Charges over the past 5 years was $30287.0 (2017), compared with a mean of $73340.4.
  • Biggest five-year swings in Amortization of Deferred Charges: surged 3221.73% in 2015 and later crashed 85.92% in 2016.
  • Aethlon Medical's Amortization of Deferred Charges stood at $134919.0 in 2015, then crashed by 85.92% to $18998.0 in 2016, then soared by 59.42% to $30287.0 in 2017, then changed by 0.0% to $30287.0 in 2018, then changed by 0.0% to $30287.0 in 2019.
  • The last three reported values for Amortization of Deferred Charges were $30287.0 (Q1 2019), $30287.0 (Q4 2018), and $30287.0 (Q3 2018) per Business Quant data.